Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
International Review of Psychiatry (Abingdon, England)
|
November 14, 2018
Current perspectives on psychedelic therapy: use of serotonergic hallucinogens in clinical interventions
Albert Garcia-Romeu, William A Richards
Psychopharmacology
|
June 16, 2011
Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects
Roland R Griffiths, Matthew W Johnson, William A Richards, et al.
Journal of Psychopharmacology (Oxford, England)
|
April 1, 2025
The Afterglow Inventory (AGI): Validation of a new instrument for measuring subacute effects of classic serotonergic psychedelics
Tomislav Majić, Timo Torsten Schmidt, Anna Gröticke, et al.
Psychedelic Medicine (New Rochelle, N.Y.)
|
March 23, 2026
Effects of Psilocybin on Religious and Spiritual Attitudes and Behaviors in Clergy from Various Major World Religions
Roland R Griffiths, Robert Jesse, William A Richards, et al.
Journal of Psychopharmacology (Oxford, England)
|
December 3, 2016
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
Roland R Griffiths, Matthew W Johnson, Michael A Carducci, et al.
International Journal of Methods in Psychiatric Research
|
April 26, 2026
Integrating the Mystical Experience Questionnaire Into a Broader Psychometric Framework: English Validation of the Psychedelic Experience Scale and Comparison of Psilocybin and LSD Sessions Across Two Controlled Settings
Kurt Stocker, Matthias Hartmann, Frederick S Barrett, et al.
Journal of Psychopharmacology (Oxford, England)
|
October 13, 2017
Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors
Roland R Griffiths, Matthew W Johnson, William A Richards, et al.
Frontiers in Psychiatry
|
March 1, 2021
Development and Evaluation of a Therapist Training Program for Psilocybin Therapy for Treatment-Resistant Depression in Clinical Research
Sara J Tai, Elizabeth M Nielson, Molly Lennard-Jones, et al.
Journal of Palliative Medicine
|
March 14, 2022
Top Ten Tips Palliative Care Clinicians Should Know About Psychedelic-Assisted Therapy in the Context of Serious Illness
William E Rosa, Zachary Sager, Megan Miller, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
International Review of Psychiatry (Abingdon, England)
|
November 14, 2018
Current perspectives on psychedelic therapy: use of serotonergic hallucinogens in clinical interventions
Albert Garcia-Romeu, William A Richards
Psychopharmacology
|
June 16, 2011
Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects
Roland R Griffiths, Matthew W Johnson, William A Richards, et al.
Journal of Psychopharmacology (Oxford, England)
|
April 1, 2025
The Afterglow Inventory (AGI): Validation of a new instrument for measuring subacute effects of classic serotonergic psychedelics
Tomislav Majić, Timo Torsten Schmidt, Anna Gröticke, et al.
Psychedelic Medicine (New Rochelle, N.Y.)
|
March 23, 2026
Effects of Psilocybin on Religious and Spiritual Attitudes and Behaviors in Clergy from Various Major World Religions
Roland R Griffiths, Robert Jesse, William A Richards, et al.
Journal of Psychopharmacology (Oxford, England)
|
December 3, 2016
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
Roland R Griffiths, Matthew W Johnson, Michael A Carducci, et al.
International Journal of Methods in Psychiatric Research
|
April 26, 2026
Integrating the Mystical Experience Questionnaire Into a Broader Psychometric Framework: English Validation of the Psychedelic Experience Scale and Comparison of Psilocybin and LSD Sessions Across Two Controlled Settings
Kurt Stocker, Matthias Hartmann, Frederick S Barrett, et al.
Journal of Psychopharmacology (Oxford, England)
|
October 13, 2017
Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors
Roland R Griffiths, Matthew W Johnson, William A Richards, et al.
Frontiers in Psychiatry
|
March 1, 2021
Development and Evaluation of a Therapist Training Program for Psilocybin Therapy for Treatment-Resistant Depression in Clinical Research
Sara J Tai, Elizabeth M Nielson, Molly Lennard-Jones, et al.
Journal of Palliative Medicine
|
March 14, 2022
Top Ten Tips Palliative Care Clinicians Should Know About Psychedelic-Assisted Therapy in the Context of Serious Illness
William E Rosa, Zachary Sager, Megan Miller, et al.
Page
of 1